Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
- Dermatology. 2012;224(2):120-5. doi: 10.1159/000337546.
- 1. Department of Dermatology, University Hospital Basel, Basel, Switzerland. [email protected]
Pityriasis rubra pilaris (PRP) includes a spectrum of rare chronic inflammatory disorders with papulosquamous eruptions of unknown cause. Different etiologies have been proposed such as vitamin A metabolism dysfunction, association with autoimmune disorders, Infection or malignancies. However, PRP seems to be a polygenic skin disorder. Classical systemic treatment is empirical and includes retinoids and methotrexate; however, only few series on treatments exist. Recently there has been an increasing number of reports documenting that new biologicals and in particular TNF-α blockers are safe and effective.